203 related articles for article (PubMed ID: 21512137)
1. c-Myc regulates RNA splicing of the A-Raf kinase and its activation of the ERK pathway.
Rauch J; Moran-Jones K; Albrecht V; Schwarzl T; Hunter K; Gires O; Kolch W
Cancer Res; 2011 Jul; 71(13):4664-74. PubMed ID: 21512137
[TBL] [Abstract][Full Text] [Related]
2. Splicing factor hnRNP A2 activates the Ras-MAPK-ERK pathway by controlling A-Raf splicing in hepatocellular carcinoma development.
Shilo A; Ben Hur V; Denichenko P; Stein I; Pikarsky E; Rauch J; Kolch W; Zender L; Karni R
RNA; 2014 Apr; 20(4):505-15. PubMed ID: 24572810
[TBL] [Abstract][Full Text] [Related]
3. Heterogeneous nuclear ribonucleoprotein H blocks MST2-mediated apoptosis in cancer cells by regulating A-Raf transcription.
Rauch J; O'Neill E; Mack B; Matthias C; Munz M; Kolch W; Gires O
Cancer Res; 2010 Feb; 70(4):1679-88. PubMed ID: 20145135
[TBL] [Abstract][Full Text] [Related]
4. DA-Raf, a dominant-negative antagonist of the Ras-ERK pathway, is a putative tumor suppressor.
Kanno E; Kawasaki O; Takahashi K; Takano K; Endo T
Exp Cell Res; 2018 Jan; 362(1):111-120. PubMed ID: 29129563
[TBL] [Abstract][Full Text] [Related]
5. Dominant-negative antagonists of the Ras-ERK pathway: DA-Raf and its related proteins generated by alternative splicing of Raf.
Endo T
Exp Cell Res; 2020 Feb; 387(2):111775. PubMed ID: 31843497
[TBL] [Abstract][Full Text] [Related]
6. DA-Raf-Mediated Suppression of the Ras--ERK Pathway Is Essential for TGF-β1-Induced Epithelial-Mesenchymal Transition in Alveolar Epithelial Type 2 Cells.
Watanabe-Takano H; Takano K; Hatano M; Tokuhisa T; Endo T
PLoS One; 2015; 10(5):e0127888. PubMed ID: 25996975
[TBL] [Abstract][Full Text] [Related]
7. The RNA-binding proteins hnRNP H and F regulate splicing of a MYC-dependent HRAS exon in prostate cancer cells.
Chen X; Yang HT; Zhang B; Phillips JW; Cheng D; Rigo F; Witte ON; Xing Y; Black DL
Proc Natl Acad Sci U S A; 2023 Jul; 120(28):e2220190120. PubMed ID: 37399401
[TBL] [Abstract][Full Text] [Related]
8. Differential localization of A-Raf regulates MST2-mediated apoptosis during epithelial differentiation.
Rauch J; Vandamme D; Mack B; McCann B; Volinsky N; Blanco A; Gires O; Kolch W
Cell Death Differ; 2016 Aug; 23(8):1283-95. PubMed ID: 26891695
[TBL] [Abstract][Full Text] [Related]
9. Myc antagonizes Ras-mediated growth arrest in leukemia cells through the inhibition of the Ras-ERK-p21Cip1 pathway.
Vaqué JP; Navascues J; Shiio Y; Laiho M; Ajenjo N; Mauleon I; Matallanas D; Crespo P; León J
J Biol Chem; 2005 Jan; 280(2):1112-22. PubMed ID: 15528212
[TBL] [Abstract][Full Text] [Related]
10. Complementation of defective colony-stimulating factor 1 receptor signaling and mitogenesis by Raf and v-Src.
Aziz N; Cherwinski H; McMahon M
Mol Cell Biol; 1999 Feb; 19(2):1101-15. PubMed ID: 9891045
[TBL] [Abstract][Full Text] [Related]
11. A modest reduction in c-myc expression has minimal effects on cell growth and apoptosis but dramatically reduces susceptibility to Ras and Raf transformation.
Bazarov AV; Adachi S; Li SF; Mateyak MK; Wei S; Sedivy JM
Cancer Res; 2001 Feb; 61(3):1178-86. PubMed ID: 11221849
[TBL] [Abstract][Full Text] [Related]
12. Induction of beta3-integrin gene expression by sustained activation of the Ras-regulated Raf-MEK-extracellular signal-regulated kinase signaling pathway.
Woods D; Cherwinski H; Venetsanakos E; Bhat A; Gysin S; Humbert M; Bray PF; Saylor VL; McMahon M
Mol Cell Biol; 2001 May; 21(9):3192-205. PubMed ID: 11287623
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of the Raf-1 kinase by cyclic AMP agonists causes apoptosis of v-abl-transformed cells.
Weissinger EM; Eissner G; Grammer C; Fackler S; Haefner B; Yoon LS; Lu KS; Bazarov A; Sedivy JM; Mischak H; Kolch W
Mol Cell Biol; 1997 Jun; 17(6):3229-41. PubMed ID: 9154822
[TBL] [Abstract][Full Text] [Related]
14. Rit contributes to nerve growth factor-induced neuronal differentiation via activation of B-Raf-extracellular signal-regulated kinase and p38 mitogen-activated protein kinase cascades.
Shi GX; Andres DA
Mol Cell Biol; 2005 Jan; 25(2):830-46. PubMed ID: 15632082
[TBL] [Abstract][Full Text] [Related]
15. A-Raf: A new star of the family of raf kinases.
An S; Yang Y; Ward R; Liu Y; Guo XX; Xu TR
Crit Rev Biochem Mol Biol; 2015; 50(6):520-31. PubMed ID: 26508523
[TBL] [Abstract][Full Text] [Related]
16. Suppression of PTEN expression is essential for antiapoptosis and cellular transformation by oncogenic Ras.
Vasudevan KM; Burikhanov R; Goswami A; Rangnekar VM
Cancer Res; 2007 Nov; 67(21):10343-50. PubMed ID: 17974977
[TBL] [Abstract][Full Text] [Related]
17. Direct recruitment of ERK cascade components to inducible genes is regulated by heterogeneous nuclear ribonucleoprotein (hnRNP) K.
Mikula M; Bomsztyk K
J Biol Chem; 2011 Mar; 286(11):9763-75. PubMed ID: 21233203
[TBL] [Abstract][Full Text] [Related]
18. DA-Raf-dependent inhibition of the Ras-ERK signaling pathway in type 2 alveolar epithelial cells controls alveolar formation.
Watanabe-Takano H; Takano K; Sakamoto A; Matsumoto K; Tokuhisa T; Endo T; Hatano M
Proc Natl Acad Sci U S A; 2014 Jun; 111(22):E2291-300. PubMed ID: 24843139
[TBL] [Abstract][Full Text] [Related]
19. DA-Raf1, a competent intrinsic dominant-negative antagonist of the Ras-ERK pathway, is required for myogenic differentiation.
Yokoyama T; Takano K; Yoshida A; Katada F; Sun P; Takenawa T; Andoh T; Endo T
J Cell Biol; 2007 Jun; 177(5):781-93. PubMed ID: 17535970
[TBL] [Abstract][Full Text] [Related]
20. C-Raf is required for the initiation of lung cancer by K-Ras(G12D).
Karreth FA; Frese KK; DeNicola GM; Baccarini M; Tuveson DA
Cancer Discov; 2011 Jul; 1(2):128-36. PubMed ID: 22043453
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
